A 28-year-old client at 6 weeks gestation, gravida 1 para 0, presents to the prenatal clinic. She has a history of seizure disorder controlled on valproic acid, and her BMI is 31. The nurse is teaching about first-trimester risk reduction. Which teaching points are essential? Select all that apply.
Select All That Apply
Choose your responses, then check the answer.
Explanation
First-trimester teratogen avoidance and folic acid supplementation are foundational primary prevention. Valproic acid carries the highest neural tube defect (NTD) risk among antiepileptics (about 10 percent major malformations) and should be switched to lamotrigine or levetiracetam if possible — coordination with neurology and obstetrics is essential (option 5). Folic acid 4 mg per day high-dose (versus the standard 0.4 to 0.8 mg) is recommended for women on antiepileptics, with prior NTD pregnancy, or with elevated BMI — it protects against NTDs when started preconception or in the earliest first trimester (option 4). Caloric restriction during pregnancy (option 6) impairs fetal growth — pregnancy is not the time for weight loss. Stopping prenatal vitamins (option 2) eliminates folic acid coverage. There is no safe alcohol level during pregnancy — fetal alcohol syndrome risk exists at any dose (option 3 false). NSAIDs are contraindicated in late pregnancy (premature ductus closure) and should be avoided in early pregnancy unless specifically directed (option 1 false).
First-Trimester Risk Reduction Critical organogenesis is the critical period for teratogen exposure. Two pillars: eliminate teratogens and folate supplementation.
Folic Acid Dosing - Standard preconception: 0.4 to 0.8 mg per day - High-dose 4 mg per day: AED use, prior NTD, BMI 30 or higher, malabsorption, sickle cell - Continue through the first trimester at minimum
Wrong Answers 3: No weight-loss diets during pregnancy. 4: Continue prenatal vitamins and switch formulation if nausea is an issue. 5: No safe alcohol level — FAS risk. 6: NSAIDs are avoided, especially after 20 weeks.
NCSBN Theme HPM — Antepartum and health promotion.
Scenario28-year-old G1P0 at 6 weeks gestation, prenatal clinic.
Risk Profile- Seizure disorder on valproic acid (high NTD risk)- BMI 31 (high-dose folate indication)- Gravida 1 — no prior NTD history
CoordinationMultidisciplinary: OB plus neurology plus dietitian.
Folic acid (high-dose 4 mg) — Synthetic folate supplement that prevents neural tube defects (anencephaly, spina bifida) when started preconception or in the earliest first trimester. Standard prevention dose: 0.4 to 0.8 mg per day. High-dose 4 mg per day is recommended for prior NTD pregnancy, antiepileptic drug use (especially valproic acid and carbamazepine), maternal BMI 30 or higher, malabsorption, and sickle cell disease. Maximum benefit at neural tube closure (day 21 to 28 post-conception).
Teratogen — A substance, infection, or environmental exposure that causes structural or functional fetal abnormality. Highest risk during organogenesis (first trimester, weeks 4 to 10). FDA pregnancy categories were replaced by PLLR (Pregnancy and Lactation Labeling Rule) in 2015. Examples: valproic acid (NTD), isotretinoin (multiple anomalies), warfarin (chondrodysplasia), ACE inhibitors (renal dysgenesis after first trimester), alcohol (FAS), tetracyclines (teeth and bone).
Primary prevention in pregnancy — Preconception and first-trimester strategies to prevent fetal abnormality before disease occurs. Pillars: folic acid, immunization (rubella, varicella, Tdap), teratogen avoidance (medications, alcohol, smoking, illicit drugs, environmental toxins), nutrition, chronic disease optimization (diabetes, hypertension, seizure disorder, thyroid), and genetic carrier screening when indicated.